ANM and ANS in Peru: DIGEMID Authority under Ley 29459

Regulatory information verified as of October 29, 2026.

1. Key takeaways

The National Health Authority (ANS = MINSA) and the National Authority for Pharmaceutical Products, Medical Devices and Sanitary Products (ANM = DIGEMID) are not two parallel regulators; they are the policy layer and the execution layer of one administrative chain. Every appealable administrative act a company encounters occurs at the ANM layer, while the predictability of the rules is decided at the ANS layer. This distinction is fixed in Ley N° 29459, published on 2009-11-26, through functional designations. Treating the two as parallel parties causes remedies to be aimed at the wrong level: challenging a ministerial rule through an individual reconsideration, or answering a directorate decision with window-level communication only, both lead to missed deadlines and lost rights. The layers also differ in the instruments they issue and the subjects they bind, which is why every compliance action should begin by identifying the instrument type, the issuing layer and the correct addressee of any challenge.

2. Legal basis

Regulatory information verified as of October 29, 2026.

3. Expert insights

Insight 1: ANM and ANS are functional designations, not agency renames.

The legal text uses these two designations to fix who performs which function, not to rename agencies. This creates a document-level risk: in powers of attorney, free sale certificates and dossier covers, self-created abbreviations for the authorities cause party-identification errors. Powers of attorney signed by foreign manufacturers must map unambiguously to the authorities referred to in the legal texts. GRZAN keeps the Spanish original designations in all document templates precisely to eliminate this layer of risk, and companies preparing their own files should adopt the same rule.

Insight 2: The form of an instrument distinguishes the layers, and it also determines the addressee of a remedy.

The ANS layer sets rules through Supreme Decrees (Decreto Supremo), such as D.S. N° 011-2026-SA published on 2026-07-21, which approved the new consolidated procedures text; the ANM layer executes through directorate resolutions (Resolución Directoral) and individual administrative decisions, such as R.D. N° 033-2017-DIGEMID-DG-MINSA published on 2017-03-12 and R.D. N° 101-2019-DIGEMID-DG-MINSA published on 2019-06-14. The remedy path therefore forks: a company dissatisfied with a specific ANM decision must, under Ley N° 27444 published on 2001-04-11 and the current TUPA, file reconsideration (Reconsideración) with the corresponding executing director within 15 working days, and then appeal (Apelación); a company dissatisfied with an ANS rule cannot change it through an individual reconsideration and can only adapt through compliance adjustments.

Insight 3: The two-layer structure explains the time lag between rules changing and windows moving.

After a ministerial decree is published, the forms, system fields and acceptance criteria of the execution layer need time to synchronize. This lag is not an enforcement vacuum; it is a risk window. A company that prepares under the new rules but files under the old window, or the reverse, produces formal non-conformity. The correct approach is to use the requirements checklist of the current TUPA as the filing baseline while using the latest ministerial decree as the technical content baseline; where the two conflict, current official DIGEMID publication controls. Companies should also date-stamp every filing against the instrument in force on the filing date, so that a later synchronization of forms cannot retroactively invalidate a submission that was formally correct when made.

4. Practical recommendations

1. Unify party names in documents: keep the Spanish original designations ANS/ANM in all external documents and avoid self-created abbreviations.
2. Manage the fork in remedies: challenge ANM decisions through reconsideration and appeal within 15 working days; respond to ANS rule changes through internal compliance adjustments, which do not consume reconsideration deadlines.
3. Separate the filing baseline from the content baseline: requirements follow the current TUPA, technical content follows the latest ministerial decree, and conflicts are resolved by official publication.
4. Track the instrument sequences of both layers: follow Supreme Decrees in El Peruano at the ministerial level, and directorate resolutions and platform announcements at the directorate level.
5. Treat reorganization information as background only: as illustrated by D.S. N° 014-2026-SA (secondary sources record publication on 2026-09-09 with a 90-calendar-day reorganization), procedural parameters follow official publication, and submission timing is not adjusted on the basis of summaries.

5. Verification checklist

□ Confirmed the functional designation mapping of ANS = MINSA and ANM = DIGEMID

□ Confirmed that authority names in external documents use the Spanish original designations

□ Confirmed that appealable administrative acts occur at the ANM layer, with remedies through reconsideration and appeal under Ley N° 27444 and the current TUPA

□ Confirmed the reconsideration filing deadline of 15 working days and registered expiry reminders

□ Confirmed that ministerial decrees and directorate resolutions are entered in separate tracking logs

□ Confirmed that reorganization information is treated as background only and is not extended into specific registration obligations

Regulatory information verified as of October 29, 2026.

GRZAN Regulatory Team

GRZAN provides medical device registration support in Peru for manufacturers, importers and authorized representatives. For inquiries, contact info@grzanglobal.com.